US20180140284A1 - Medical Toilet with User Customized Health Metric Validation System - Google Patents
Medical Toilet with User Customized Health Metric Validation System Download PDFInfo
- Publication number
- US20180140284A1 US20180140284A1 US15/360,101 US201615360101A US2018140284A1 US 20180140284 A1 US20180140284 A1 US 20180140284A1 US 201615360101 A US201615360101 A US 201615360101A US 2018140284 A1 US2018140284 A1 US 2018140284A1
- Authority
- US
- United States
- Prior art keywords
- measurement
- medical
- user
- urine
- toilet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000036541 health Effects 0.000 title claims description 13
- 238000010200 validation analysis Methods 0.000 title description 4
- 238000005259 measurement Methods 0.000 claims abstract description 170
- 210000002700 urine Anatomy 0.000 claims description 32
- 239000003814 drug Substances 0.000 claims description 18
- 229940079593 drug Drugs 0.000 claims description 17
- 210000002966 serum Anatomy 0.000 claims description 14
- 238000004364 calculation method Methods 0.000 claims description 9
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 claims description 8
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims description 8
- 230000002550 fecal effect Effects 0.000 claims description 8
- 102000001554 Hemoglobins Human genes 0.000 claims description 6
- 108010054147 Hemoglobins Proteins 0.000 claims description 6
- 239000002207 metabolite Substances 0.000 claims description 6
- 230000036772 blood pressure Effects 0.000 claims description 5
- 238000003745 diagnosis Methods 0.000 claims description 5
- 238000002483 medication Methods 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 238000004458 analytical method Methods 0.000 claims description 4
- 229940109239 creatinine Drugs 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 4
- 238000012986 modification Methods 0.000 claims description 4
- 230000004048 modification Effects 0.000 claims description 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 4
- 229940127557 pharmaceutical product Drugs 0.000 claims description 4
- OBHRVMZSZIDDEK-UHFFFAOYSA-N urobilinogen Chemical compound CCC1=C(C)C(=O)NC1CC1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(CC3C(=C(CC)C(=O)N3)C)N2)CCC(O)=O)N1 OBHRVMZSZIDDEK-UHFFFAOYSA-N 0.000 claims description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 3
- 239000010796 biological waste Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 claims description 2
- 108010082126 Alanine transaminase Proteins 0.000 claims description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 2
- 108010003415 Aspartate Aminotransferases Proteins 0.000 claims description 2
- 102000004625 Aspartate Aminotransferases Human genes 0.000 claims description 2
- 102000011022 Chorionic Gonadotropin Human genes 0.000 claims description 2
- 108010062540 Chorionic Gonadotropin Proteins 0.000 claims description 2
- 101710107035 Gamma-glutamyltranspeptidase Proteins 0.000 claims description 2
- 101710173228 Glutathione hydrolase proenzyme Proteins 0.000 claims description 2
- 102000004877 Insulin Human genes 0.000 claims description 2
- 108090001061 Insulin Proteins 0.000 claims description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 2
- 108010063045 Lactoferrin Proteins 0.000 claims description 2
- 102100032241 Lactotransferrin Human genes 0.000 claims description 2
- 102000001109 Leukocyte L1 Antigen Complex Human genes 0.000 claims description 2
- 108010069316 Leukocyte L1 Antigen Complex Proteins 0.000 claims description 2
- 102100027378 Prothrombin Human genes 0.000 claims description 2
- 108010094028 Prothrombin Proteins 0.000 claims description 2
- 102000007562 Serum Albumin Human genes 0.000 claims description 2
- 108010071390 Serum Albumin Proteins 0.000 claims description 2
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 claims description 2
- 239000004202 carbamide Substances 0.000 claims description 2
- 150000003943 catecholamines Chemical class 0.000 claims description 2
- 230000005684 electric field Effects 0.000 claims description 2
- 239000003792 electrolyte Substances 0.000 claims description 2
- 210000003743 erythrocyte Anatomy 0.000 claims description 2
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 claims description 2
- 230000005484 gravity Effects 0.000 claims description 2
- 238000005534 hematocrit Methods 0.000 claims description 2
- 229940084986 human chorionic gonadotropin Drugs 0.000 claims description 2
- 229960000890 hydrocortisone Drugs 0.000 claims description 2
- 229940125396 insulin Drugs 0.000 claims description 2
- 150000002576 ketones Chemical class 0.000 claims description 2
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims description 2
- 229940078795 lactoferrin Drugs 0.000 claims description 2
- 235000021242 lactoferrin Nutrition 0.000 claims description 2
- 210000000265 leukocyte Anatomy 0.000 claims description 2
- 238000012544 monitoring process Methods 0.000 claims description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 2
- 235000018102 proteins Nutrition 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 229940039716 prothrombin Drugs 0.000 claims description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 2
- 230000035945 sensitivity Effects 0.000 claims description 2
- 238000004611 spectroscopical analysis Methods 0.000 claims description 2
- 238000012360 testing method Methods 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims 4
- 230000003636 fecal output Effects 0.000 claims 1
- 238000000691 measurement method Methods 0.000 abstract description 2
- 238000000034 method Methods 0.000 description 12
- 230000000284 resting effect Effects 0.000 description 11
- 230000003862 health status Effects 0.000 description 10
- 238000009532 heart rate measurement Methods 0.000 description 10
- 241000124008 Mammalia Species 0.000 description 6
- 210000000577 adipose tissue Anatomy 0.000 description 6
- 230000035790 physiological processes and functions Effects 0.000 description 5
- 230000037396 body weight Effects 0.000 description 4
- 210000001715 carotid artery Anatomy 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 102000015779 HDL Lipoproteins Human genes 0.000 description 3
- 108010010234 HDL Lipoproteins Proteins 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000012773 Laboratory assay Methods 0.000 description 2
- 238000013479 data entry Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000003270 steroid hormone Substances 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 238000005353 urine analysis Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0038—Devices for taking faeces samples; Faecal examination devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
- A61B10/007—Devices for taking samples of body liquids for taking urine samples
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0004—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
- A61B5/0006—ECG or EEG signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/021—Measuring pressure in heart or blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6887—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient mounted on external non-worn devices, e.g. non-medical devices
- A61B5/6891—Furniture
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0223—Operational features of calibration, e.g. protocols for calibrating sensors
Definitions
- This invention relates to systems for determining health conditions.
- Each measurement may have a different shortcoming that must be taken into account when interpreting the data generated by the measurement. Included in the shortcomings are that the healthcare provider must be aware of inherent instrumental error, interpret the results based on the patient's physical status including body type, medical diagnosis, and current medications, and be aware of the instrumental error associated with a particular measurement event. The latter error may be related to the user's physical status and is particularly difficult for a healthcare provider to estimate when viewing measurement results. This is, at least in part, because the healthcare provider that conducted the measurement may not be the same healthcare provider that analyzes the results. Consequently, the healthcare provider analyzing the results may be unaware of difficulties that occurred during the measurement process. For example, with the growing use of telemedicine, a specialist may consult on a patient he or she has never met. A way to determine the level of accuracy of health-related data, select measurements that are relevant to the particular patient, and to put the data in proper context based on the user's physical status is needed.
- a medical toilet that collects measurements pertaining to a user's health status and which includes a system for identifying the level of validity of the measurements.
- the system is customized to each user based on physical and demographical information and medical history.
- the system includes a controller which receives information about a user's physical, demographical, and medical status.
- the medical toilet may conduct a first measurement which is relevant to the user's health and a second measurement which is an indicator of the validity of the first measurement.
- the controller may select the type or measurement techniques, the anatomical location from which the measurements are taken, and it may modify the parameters of the instruments taking the measurements all based on the information stored about the user in the controller.
- the first and second measurements may be analyzed according to at least one set of rules which assign a weight value to the first measurement.
- the first and second sets of rules may also vary depending on the user's physical, demographical, and medical status information stored in the controller, including, but not limited to body type, gender, skeletal structure (fine or heavy), medical diagnosis, and current medications.
- the information may determine which of a plurality of sets of rules are applied to the measurements. New physical status information about the user may be periodically entered into the controller to trigger an alternative set of rules.
- the system may trigger the collection of a follow-up measurement, which may confirm or contradict the first measurement.
- the controller may select the follow-up measurement based on the user's physical, demographical, and medical status information.
- Some embodiments of the medical toilet may transmit the measurements and calculations to a network database.
- a healthcare provider may download the data to a user's medical file. Changes to the user's physical status may be transmitted to the medical toilet from a controller located at a remote location so that the medical toilet continues to select the proper measurements, parameters, and rules to apply to collected data.
- this system adjusts the measurements themselves, including how they are taken with relation to the user's anatomy, the parameters of the instrumentation, as well as assessing the validity of the measurement to provide a customized set of measurements. Initial measurements are adjusted based on input about a user's physical, demographic, and medical status, their validity assessed, then more measurements may be taken with further adjustment. Both the validity of the measurement and the relevance to the user is thereby optimized.
- FIG. 1 is a perspective view of an embodiment of the invention in which a first and second measurement are collected by a medical toilet and the data is transferred to a controller.
- FIG. 2 is a perspective view of an embodiment of the invention in which user information is entered into the controller of a medical toilet and both a first and second measurement are collected by a medical toilet.
- FIG. 3 is a flow chart illustrating an embodiment of the invention in which the controller calculates a numerical indicator of the validity of the first measurement.
- FIG. 4 is a flow chart illustrating an example of a method of use of an embodiment of the invention in which user information is entered into the controller, measurements are conducted, and modifications of the measuring technique are made with reference to the user information.
- FIG. 5 is a flow chart illustrating an example of the use of an embodiment of the invention in which updated user information is needed.
- FIG. 6 is a diagram illustrating an embodiment of the invention in which the controller selects measurements, modifies the parameters for collecting some measurements, and determines which calculations to perform based on user information.
- FIG. 7 is a flow chart illustrating a process according to an embodiment of an invention in which the toilet conducts follow-up measurements in response to a first measurement and a user's medical history.
- Toilet as used herein, means a device that collects biological waste products of a mammal, including urine and feces.
- Medical toilet means a toilet that conducts one or more measurements relevant to a user's health status. This may include, but is not limited to, quantification of analytes in urine or feces, cardiovascular parameters, bioimpedance measurements, and body weight.
- Health status means the current physiological state of a mammal, particularly with regard to disease status or injury. In general, this term refers to the overall health of the mammal. However, individual parameters relating to a specific body part or biological system may be measured for the purpose of diagnosing disease states or identifying physiological characteristics or functions that are outside of the normal range. Such individual physiological characteristics or functions may be used to define the health status of the mammal with regard to a specific physiological system.
- User means any mammal, human or animal, for which the medical toilet disclosed herein is used to measure physiological functions which may be used to assess the mammal's health status.
- Healthcare provider means any individual who performs a task, mental or physical, in relation to health-related services provided to a user.
- the term healthcare provider includes any person that enters data into a computer, when the data entry is used in analysis of a user's health status or to improve a user's health.
- the toilet includes a system for customizing the measurements for each user, validating the accuracy of the measurements, and both selecting and performing follow-up measurements that may be needed.
- the system uses physical, demographical, and medical status information about the user, not just to interpret the measurements, but to make adjustments within the medical toilet and instruments therein to optimally perform the measurements for each user.
- the physical, demographic, and medical status information may include a body type, including, but not limited to, endurance athlete, weight bearing athlete, non-athlete, male, female, under a defined age, over a defined age, fine skeletal structure, and heavy skeletal structure.
- the medical status information may also comprise a medical diagnosis and the user's current medications, each of which, may impact reasonable interpretation of the measurements, alter which measurement is most useful for the specific user, and the parameters under which the measurement is taken.
- Medical devices are typically designed to be used in the same way for each user.
- the optimal parameters to conduct a measurement with a particular medical device vary from user to user.
- parameters that may be adjusted based on physical, demographic, and medical status information include, but are not limited to, power level, wavelength of a light source in a spectroscopy instrument, frequency of alternative current electric field, instrument sensitivity, instrument dynamic range, length of measurement time, applied voltage, anatomical location at which the first or second measurement is taken, sample rate, sample volume, and data filter bandwidth.
- a controller within or connected to the medical toilet may use the physical, demographical, and medical status information to predict the optimal parameters to use with each instrument when collecting measurements for a particular user.
- the type of measurement that is optimal for a user varies according to physical, demographic, or medical status. For example, reliable bioimpedance measurements taken from the thigh may be difficult to obtain from obese users. Therefore, measuring bioimpedance from a different anatomical site on an obese user or conducting a measurement other than bioimpedance may yield more a more useful measurement.
- a measurement that requires a user to remain still for a length of time may be suboptimal for young children.
- a user whose disease status or medications cause the user to have a faint pulse. This user may need to have a heart rate measured through the carotid artery, which typically gives a strong signal as compared to the wrist, to acquire a meaningful heart rate measurement.
- the validity of a first measurement is assessed by conducting a second measurement.
- a general explanation of the method to determine the validity of the first measurement is provided in Applicant's U.S. patent application Ser. Nos. 15/270,674 and 15/279,734 which are hereby incorporated by reference in their entirety.
- a first set of rules may be applied to the first and second measurements which results in a weight value.
- the weight value is assigned to the first measurement and may be a function of the second measurement.
- a second set of rules may be applied to the first measurement and the weight value to calculate an indicator value.
- the indicator value assigns an estimate of validity to the first measurement and, consequently, informs its relevance to a user's health status.
- the second set of rules may define a threshold value for the weight value and may signal the controller to flag the first measurement as invalid or to be excluded from multi-variable calculations that provide an assessment of the user's health status.
- a clinician may choose to interpret a first measurement that has a mid-range indicator value in combination with more reliable measurements to bolster the validity of a general trend shown by the first measurement. Thus, the first measurement may provide some value but is not assigned more relevance than it merits.
- the rule sets may vary for each user as a function of the physical, demographical, and medical information stored in the controller for that user. This is at least because a measurement that may seem suspect for one user may be expected for another user depending on physical, demographical, or medical differences between the two users. Thus, the estimate of validity may be dependent on the physical, demographical, and medical information provided for the user.
- FIG. 1 illustrates an embodiment of the customized measurement validation system 400 , which is an embodiment of the disclosed invention.
- both first measurement 420 and second measurement 430 are collected by medical devices within medical toilet 205 .
- the arrows indicate that first and second measurements 420 and 430 are transmitted to controller 115 .
- Controller 115 then applies the first and second rule sets based, at least in part, on a user's physical and demographical status information.
- the rule sets controller 115 applies may be selected based on the physical and demographic status information and may vary with each user.
- the dashed lines indicate that, in this embodiment, computer 115 is positioned within medical toilet 205 .
- computer 115 may be a controller on or within the medical toilet, a server, a computer in a healthcare facility, or any other computing device that may receive and store data, be programed to perform calculations on the data, and provide an output of the calculated data.
- FIG. 1 illustrates a single first measurement and a single second measurement
- multiple second measurements may be collected and used as described herein to assess the validity of the first measurement.
- a single second measurement may be used to assess the validity of multiple first measurements.
- the single or multiple first and second measurements may be selected by the controller based on the user's physical, demographic, and medical status information.
- Medical toilet 205 may conduct a plurality of measurements including, but not limited to, body temperature, body weight, body composition (i.e. percent body fat, intracellular and/or extracellular water), heart rate, pedal pulse rate, blood pressure, blood oxygen saturation, electrocardiogram measurement, urine constituents and parameters including urine color, glucose, urea, creatinine, specific gravity, urine protein, electrolytes, urine pH, osmolality, human chorionic gonadotropin (for detecting pregnancy), hemoglobin, white blood cells, red blood cells, ketone bodies, bilirubin, urobilinogen, free catecholamines, free cortisol, phenylalanine, and urine volume.
- body temperature body weight
- body composition i.e. percent body fat, intracellular and/or extracellular water
- heart rate i.e. percent body fat, intracellular and/or extracellular water
- pedal pulse rate blood pressure
- blood oxygen saturation i.e. percent body fat, intracellular and/or extracellular water
- blood pressure i.
- the measurements may also include fecal analysis including fecal weight and volume, calprotectin, lactoferrin, hemoglobin, stress test, blood pressure, hematocrit, serum insulin level, hemoglobin A1c, breathing rate, blood urea nitrogen, serum creatinine, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, serum bilirubin, serum total protein, serum albumin, serum gamma-glutamyl transpeptidase, prothrombin time, Holter monitoring, serum levels of a pharmaceutical product, and serum levels of a metabolite of a pharmaceutical product.
- fecal analysis including fecal weight and volume, calprotectin, lactoferrin, hemoglobin, stress test, blood pressure, hematocrit, serum insulin level, hemoglobin A1c, breathing rate, blood urea nitrogen, serum creatinine, alanine aminotransferase, aspartate aminotransferase
- sensors that measure flow, volume, or weight may determine periods of excretion activity to measure, for instance, urination or defecation exertions, or selectively record measurements that were collected during periods of low exertion. These measurements are useful because certain other measurements are best performed after complete voiding of the bowel and bladder for maximum accuracy.
- FIG. 2 illustrates an embodiment of the customized measurement validation system 700 .
- FIG. 2 shows a user's physical, demographic, and medical status information, which indicates that the user is a female endurance athlete with a fine bone structure. This information is entered into controller 115 and stored in a user information file. As described elsewhere herein, different physiological characteristics associated with a user may impact the most accurate and meaningful interpretation of the first health measurement as well as which measurements should be collected for that user and their optimal collection parameters. The controller uses this information to select appropriate measurements and appropriate collection parameters for performing the measurements for this user. The controller then applies the appropriate set of rules based on the user's physical, demographic, and medical status information to assess the validity of the first measurement.
- FIG. 3 is a flow chart illustrating a method of using an embodiment of the customized measurement validation system.
- the embodiment includes a controller into which the user's physical, demographic, and medical status information is entered and stored. This step may occur by manual data entry or a variety electronic transmission methods known in the art.
- the controller analyzes the physical, demographic, and medical status stored in the information file and uses it to select an optimal first measurement to assess a particular physiological function.
- the controller also selects a second measurement for validating the first measurement and also determines parameter adjustments that may be used to optimize the first and second measurements. These may also be based on the controller's analysis of the user's physical, demographic, and medical status in the information file.
- the first and second measurements are transferred into the controller and the controller applies a first and second rule sets to the first and second measurements.
- the rule sets may be chosen based on the user's physical, demographic, and medical status in the user information file.
- the controller assigns an indicator value to the first measurement which is determined by the application of the rule sets, is a function of the second measurement, and which is an indication of the validity of the first measurement.
- a healthcare provider may use this indicator value to make a decision about the use of the first measurement. For example, the healthcare provider may decide to use the first measurement as an indicator of a user's health status, to consider the first measurement but conduct further clinical investigation, or to ignore the first measurement as an inaccurate data point.
- FIG. 4 is a flow chart illustrating how a measurement parameter may be adjusted according to an embodiment of the invention.
- FIG. 4 illustrates the step of entering information about the user into the user information file in the controller.
- the information includes the fact that the user is a male endurance athlete. This information suggests that the user may have a low percent body fat, significant muscle tone, and, in particular, a low resting heart rate.
- the user sits on the medical toilet which conducts measurements that include a resting heart rate measurement (the first measurement) and an electrocardiogram (EKG) reading (the second measurement). Because the user is an endurance athlete, the controller instructs the toilet to extend the time of collection of the resting heart rate measurement in order to collect a statistically significant number of cardiac contraction events.
- EKG electrocardiogram
- the two measurements are transmitted to the controller which uses the EKG reading to determine the validity of the resting heart rate measurement. If the resting heart rate measurement is assigned an indicator value that suggests a valid measurement, the controller may store this information. The next time the same user requires a resting heart rate measurement, the controller may signal the medical toilet to conduct the measurement under the same parameters. Alternatively, if the indicator value suggests that the resting heart rate measurement as conducted did not result in a valid measurement, the controller may signal the medical toilet to adjust the parameters under which the measurement is taken and repeat the measurement using the modified parameters. In this example, the controller signaled the medical toilet to both lengthen the collection time and measure the resting heart rate through a different part of the user's body. If these parameters are successful, the controller will record them and the next resting heart rate measurement for this user may be conducted according to the second set of parameters. Consequently, the system is able to “learn” the best method to measure a particular physiological event for each user.
- FIG. 5 illustrates a scenario in which the measurements produced data that are significantly inconsistent with the physical, demographical, and medical status information stored in the user information file for that user.
- the physical, demographical, and medical status information that is stored in the user information file indicates that the user is an obese female whose height is 5 foot 2 inches.
- the user sits on the medical toilet and the controller signals the medical toilet to measure bioimpedance, body weight, and blood pressure.
- the data collected by the measurements are transmitted to the controller.
- the controller analyzes the measurements and determines that the values are not consistent with those expected for an obese female whose height is 5 foot 2 inches.
- the measurements may have indicated that the user's body weight is 120 pounds, her blood pressure is within the lower end of the normal range for a healthy adult, and a body fat calculation may have provided a low value.
- the controller may then instruct the medical toilet to repeat the measurements using parameters that it would have selected for a non-obese user.
- the controller may provide a report which includes both sets of measurements, noting the inconsistency with the physical, demographical, and medical status information provided for that user in her user information file.
- the controller may also suggest that the physical, demographical, and medical status information in that user's user information file should be updated (perhaps the user lost significant body fat) or that the wrong user identification information was entered prior to performing the measurements.
- FIG. 6 is a diagram illustrating a scenario in which the controller uses physical, demographical, and medical status in the user information file to select appropriate measurements, to select appropriate calculations to be performed using the data collected by the measurements, as well as appropriate adjustable parameters to use when conducting the measurements.
- the user is a female endurance athlete who is diabetic and on medication for her diabetes.
- One of the chosen measurements is resting heart rate.
- an endurance athlete may have a low resting heart rate. For this reason, the controller adjusts the parameters of the measurement to increase the time the heart rate is measured and to measure the heart rate in the user's neck where the carotid artery is located.
- the carotid artery is expected to give a stronger signal than other parts of the body.
- a female endurance athlete often has reduced levels of steroid hormones which may interfere with normal menstrual cycling and fertility. For this reason, the controller signals the toilet to measure urine steroid hormones and to adjust the parameters to accurately measure within a lower than normal range of detection.
- This user is likely to have a low percent body fat so the measurements that will be used to calculate body fat will also be adjusted to accurately measure within a low range of detection.
- An athlete is likely to have elevated serum high density lipoproteins (HDL) so the parameters are adjusted to accurately measure HDLs in the upper range.
- Body mass index (BMI) is not meaningful for very fit individuals so this calculation is not performed or reported.
- the controller signals the medical toilet to measure serum glucose levels and quantify the amount of her medication or metabolites thereof in her urine.
- the latter may be used to confirm drug compliance or, along with serum glucose levels, to assess the appropriateness of her prescribed drug and its dosage.
- FIG. 7 is a flow chart illustrating a method of using an embodiment of the invention to confirm drug compliance and appropriateness of dosage.
- the physical, demographical, and medical status stored in the user's user information file in the controller indicates that the user is on a prescription medication that has a common side effect of lowered heart rate. Therefore, the controller selects a heart rate measurement for this user to determine if the drug has lowered the user's heart rate to an unsafe level.
- the chosen parameters are an extended measurement time and collection from the user's neck near the carotid artery in an attempt to get a valid measurement from a user that may have a slow heart rate.
- the heart rate measurement indicates that the user has an elevated heart rate. This is an unexpected result for a user who is currently taking this drug.
- the controller signals the medical toilet to measure the presence of the user's drug or metabolites thereof in the user's urine. If the urine analysis indicates low or absent drug in the user's body, the controller may provide a report suggesting that the user has not taken the medication, the dosage is too low, or a different medication may be appropriate.
Abstract
Description
- This invention relates to systems for determining health conditions.
- Every method of measuring physiological functions has inherent limitations. Medical devices and laboratory assays may provide inaccurate results for various reasons including user error, damaged components, or attempts to use the device or assay under conditions for which it was not designed. There are also circumstances under which the medical device or laboratory assay provides data that may not be properly interpreted without knowing specific information about the patient which puts the data in proper context. Furthermore, calculated health indices, for example, Body Mass Index (BMI), are not meaningful for all body types. Additionally, health care providers sometimes simultaneously use multiple clinical measurements, each associated with a different degree of accuracy and relevance to a particular patient, to create a complex assessment of an individual's health or to select a single diagnosis out of a lengthy differential diagnosis. Each measurement may have a different shortcoming that must be taken into account when interpreting the data generated by the measurement. Included in the shortcomings are that the healthcare provider must be aware of inherent instrumental error, interpret the results based on the patient's physical status including body type, medical diagnosis, and current medications, and be aware of the instrumental error associated with a particular measurement event. The latter error may be related to the user's physical status and is particularly difficult for a healthcare provider to estimate when viewing measurement results. This is, at least in part, because the healthcare provider that conducted the measurement may not be the same healthcare provider that analyzes the results. Consequently, the healthcare provider analyzing the results may be unaware of difficulties that occurred during the measurement process. For example, with the growing use of telemedicine, a specialist may consult on a patient he or she has never met. A way to determine the level of accuracy of health-related data, select measurements that are relevant to the particular patient, and to put the data in proper context based on the user's physical status is needed.
- We disclose a medical toilet that collects measurements pertaining to a user's health status and which includes a system for identifying the level of validity of the measurements. The system is customized to each user based on physical and demographical information and medical history. The system includes a controller which receives information about a user's physical, demographical, and medical status. The medical toilet may conduct a first measurement which is relevant to the user's health and a second measurement which is an indicator of the validity of the first measurement. The controller may select the type or measurement techniques, the anatomical location from which the measurements are taken, and it may modify the parameters of the instruments taking the measurements all based on the information stored about the user in the controller. The first and second measurements may be analyzed according to at least one set of rules which assign a weight value to the first measurement.
- The first and second sets of rules may also vary depending on the user's physical, demographical, and medical status information stored in the controller, including, but not limited to body type, gender, skeletal structure (fine or heavy), medical diagnosis, and current medications. The information may determine which of a plurality of sets of rules are applied to the measurements. New physical status information about the user may be periodically entered into the controller to trigger an alternative set of rules. The system may trigger the collection of a follow-up measurement, which may confirm or contradict the first measurement. Furthermore, the controller may select the follow-up measurement based on the user's physical, demographical, and medical status information.
- Some embodiments of the medical toilet may transmit the measurements and calculations to a network database. A healthcare provider may download the data to a user's medical file. Changes to the user's physical status may be transmitted to the medical toilet from a controller located at a remote location so that the medical toilet continues to select the proper measurements, parameters, and rules to apply to collected data.
- In addition to interpreting measurements based on a user's physical characteristics, this system adjusts the measurements themselves, including how they are taken with relation to the user's anatomy, the parameters of the instrumentation, as well as assessing the validity of the measurement to provide a customized set of measurements. Initial measurements are adjusted based on input about a user's physical, demographic, and medical status, their validity assessed, then more measurements may be taken with further adjustment. Both the validity of the measurement and the relevance to the user is thereby optimized.
-
FIG. 1 is a perspective view of an embodiment of the invention in which a first and second measurement are collected by a medical toilet and the data is transferred to a controller. -
FIG. 2 is a perspective view of an embodiment of the invention in which user information is entered into the controller of a medical toilet and both a first and second measurement are collected by a medical toilet. -
FIG. 3 is a flow chart illustrating an embodiment of the invention in which the controller calculates a numerical indicator of the validity of the first measurement. -
FIG. 4 is a flow chart illustrating an example of a method of use of an embodiment of the invention in which user information is entered into the controller, measurements are conducted, and modifications of the measuring technique are made with reference to the user information. -
FIG. 5 is a flow chart illustrating an example of the use of an embodiment of the invention in which updated user information is needed. -
FIG. 6 is a diagram illustrating an embodiment of the invention in which the controller selects measurements, modifies the parameters for collecting some measurements, and determines which calculations to perform based on user information. -
FIG. 7 is a flow chart illustrating a process according to an embodiment of an invention in which the toilet conducts follow-up measurements in response to a first measurement and a user's medical history. - Toilet, as used herein, means a device that collects biological waste products of a mammal, including urine and feces.
- Medical toilet, as used herein, means a toilet that conducts one or more measurements relevant to a user's health status. This may include, but is not limited to, quantification of analytes in urine or feces, cardiovascular parameters, bioimpedance measurements, and body weight.
- Health status, as used herein, means the current physiological state of a mammal, particularly with regard to disease status or injury. In general, this term refers to the overall health of the mammal. However, individual parameters relating to a specific body part or biological system may be measured for the purpose of diagnosing disease states or identifying physiological characteristics or functions that are outside of the normal range. Such individual physiological characteristics or functions may be used to define the health status of the mammal with regard to a specific physiological system.
- User, as used herein, means any mammal, human or animal, for which the medical toilet disclosed herein is used to measure physiological functions which may be used to assess the mammal's health status.
- Healthcare provider, as used herein, means any individual who performs a task, mental or physical, in relation to health-related services provided to a user. In addition to clinicians who practice medicine directly on a user, the term healthcare provider includes any person that enters data into a computer, when the data entry is used in analysis of a user's health status or to improve a user's health.
- While this invention is susceptible of embodiment in many different forms, there are shown in the drawings, which will herein be described in detail, several specific embodiments with the understanding that the present disclosure is to be considered as an exemplification of the principals of the invention and is not intended to limit the invention to the illustrated embodiments.
- Disclosed herein is a method and apparatus for using a medical toilet to conduct customized measurements that provide information about a user's health status. Importantly, the toilet includes a system for customizing the measurements for each user, validating the accuracy of the measurements, and both selecting and performing follow-up measurements that may be needed. The system uses physical, demographical, and medical status information about the user, not just to interpret the measurements, but to make adjustments within the medical toilet and instruments therein to optimally perform the measurements for each user. The physical, demographic, and medical status information may include a body type, including, but not limited to, endurance athlete, weight bearing athlete, non-athlete, male, female, under a defined age, over a defined age, fine skeletal structure, and heavy skeletal structure. The medical status information may also comprise a medical diagnosis and the user's current medications, each of which, may impact reasonable interpretation of the measurements, alter which measurement is most useful for the specific user, and the parameters under which the measurement is taken.
- Medical devices are typically designed to be used in the same way for each user. However, in some instances, the optimal parameters to conduct a measurement with a particular medical device vary from user to user. Examples of parameters that may be adjusted based on physical, demographic, and medical status information include, but are not limited to, power level, wavelength of a light source in a spectroscopy instrument, frequency of alternative current electric field, instrument sensitivity, instrument dynamic range, length of measurement time, applied voltage, anatomical location at which the first or second measurement is taken, sample rate, sample volume, and data filter bandwidth. A controller within or connected to the medical toilet may use the physical, demographical, and medical status information to predict the optimal parameters to use with each instrument when collecting measurements for a particular user.
- In addition to the parameters used to perform a measurement, often, the type of measurement that is optimal for a user varies according to physical, demographic, or medical status. For example, reliable bioimpedance measurements taken from the thigh may be difficult to obtain from obese users. Therefore, measuring bioimpedance from a different anatomical site on an obese user or conducting a measurement other than bioimpedance may yield more a more useful measurement. In other example, a measurement that requires a user to remain still for a length of time may be suboptimal for young children. In still another example, a user whose disease status or medications cause the user to have a faint pulse. This user may need to have a heart rate measured through the carotid artery, which typically gives a strong signal as compared to the wrist, to acquire a meaningful heart rate measurement.
- According to an embodiment of the invention, the validity of a first measurement is assessed by conducting a second measurement. A general explanation of the method to determine the validity of the first measurement is provided in Applicant's U.S. patent application Ser. Nos. 15/270,674 and 15/279,734 which are hereby incorporated by reference in their entirety. A first set of rules may be applied to the first and second measurements which results in a weight value. The weight value is assigned to the first measurement and may be a function of the second measurement. A second set of rules may be applied to the first measurement and the weight value to calculate an indicator value. The indicator value assigns an estimate of validity to the first measurement and, consequently, informs its relevance to a user's health status. The second set of rules may define a threshold value for the weight value and may signal the controller to flag the first measurement as invalid or to be excluded from multi-variable calculations that provide an assessment of the user's health status. A clinician may choose to interpret a first measurement that has a mid-range indicator value in combination with more reliable measurements to bolster the validity of a general trend shown by the first measurement. Thus, the first measurement may provide some value but is not assigned more relevance than it merits. The rule sets may vary for each user as a function of the physical, demographical, and medical information stored in the controller for that user. This is at least because a measurement that may seem suspect for one user may be expected for another user depending on physical, demographical, or medical differences between the two users. Thus, the estimate of validity may be dependent on the physical, demographical, and medical information provided for the user.
- Referring now to the figures,
FIG. 1 illustrates an embodiment of the customizedmeasurement validation system 400, which is an embodiment of the disclosed invention. In this embodiment, bothfirst measurement 420 andsecond measurement 430 are collected by medical devices withinmedical toilet 205. The arrows indicate that first andsecond measurements controller 115.Controller 115 then applies the first and second rule sets based, at least in part, on a user's physical and demographical status information. The rule setscontroller 115 applies may be selected based on the physical and demographic status information and may vary with each user. The dashed lines indicate that, in this embodiment,computer 115 is positioned withinmedical toilet 205. While schematically depicted as a laptop computer,computer 115 may be a controller on or within the medical toilet, a server, a computer in a healthcare facility, or any other computing device that may receive and store data, be programed to perform calculations on the data, and provide an output of the calculated data. - While
FIG. 1 illustrates a single first measurement and a single second measurement, multiple second measurements may be collected and used as described herein to assess the validity of the first measurement. Alternatively, a single second measurement may be used to assess the validity of multiple first measurements. The single or multiple first and second measurements may be selected by the controller based on the user's physical, demographic, and medical status information. -
Medical toilet 205 may conduct a plurality of measurements including, but not limited to, body temperature, body weight, body composition (i.e. percent body fat, intracellular and/or extracellular water), heart rate, pedal pulse rate, blood pressure, blood oxygen saturation, electrocardiogram measurement, urine constituents and parameters including urine color, glucose, urea, creatinine, specific gravity, urine protein, electrolytes, urine pH, osmolality, human chorionic gonadotropin (for detecting pregnancy), hemoglobin, white blood cells, red blood cells, ketone bodies, bilirubin, urobilinogen, free catecholamines, free cortisol, phenylalanine, and urine volume. The measurements may also include fecal analysis including fecal weight and volume, calprotectin, lactoferrin, hemoglobin, stress test, blood pressure, hematocrit, serum insulin level, hemoglobin A1c, breathing rate, blood urea nitrogen, serum creatinine, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, serum bilirubin, serum total protein, serum albumin, serum gamma-glutamyl transpeptidase, prothrombin time, Holter monitoring, serum levels of a pharmaceutical product, and serum levels of a metabolite of a pharmaceutical product. Additionally, sensors that measure flow, volume, or weight may determine periods of excretion activity to measure, for instance, urination or defecation exertions, or selectively record measurements that were collected during periods of low exertion. These measurements are useful because certain other measurements are best performed after complete voiding of the bowel and bladder for maximum accuracy. -
FIG. 2 illustrates an embodiment of the customizedmeasurement validation system 700.FIG. 2 shows a user's physical, demographic, and medical status information, which indicates that the user is a female endurance athlete with a fine bone structure. This information is entered intocontroller 115 and stored in a user information file. As described elsewhere herein, different physiological characteristics associated with a user may impact the most accurate and meaningful interpretation of the first health measurement as well as which measurements should be collected for that user and their optimal collection parameters. The controller uses this information to select appropriate measurements and appropriate collection parameters for performing the measurements for this user. The controller then applies the appropriate set of rules based on the user's physical, demographic, and medical status information to assess the validity of the first measurement. -
FIG. 3 is a flow chart illustrating a method of using an embodiment of the customized measurement validation system. The embodiment includes a controller into which the user's physical, demographic, and medical status information is entered and stored. This step may occur by manual data entry or a variety electronic transmission methods known in the art. The controller analyzes the physical, demographic, and medical status stored in the information file and uses it to select an optimal first measurement to assess a particular physiological function. The controller also selects a second measurement for validating the first measurement and also determines parameter adjustments that may be used to optimize the first and second measurements. These may also be based on the controller's analysis of the user's physical, demographic, and medical status in the information file. The first and second measurements are transferred into the controller and the controller applies a first and second rule sets to the first and second measurements. The rule sets may be chosen based on the user's physical, demographic, and medical status in the user information file. The controller assigns an indicator value to the first measurement which is determined by the application of the rule sets, is a function of the second measurement, and which is an indication of the validity of the first measurement. A healthcare provider may use this indicator value to make a decision about the use of the first measurement. For example, the healthcare provider may decide to use the first measurement as an indicator of a user's health status, to consider the first measurement but conduct further clinical investigation, or to ignore the first measurement as an inaccurate data point. -
FIG. 4 is a flow chart illustrating how a measurement parameter may be adjusted according to an embodiment of the invention.FIG. 4 illustrates the step of entering information about the user into the user information file in the controller. In this case, the information includes the fact that the user is a male endurance athlete. This information suggests that the user may have a low percent body fat, significant muscle tone, and, in particular, a low resting heart rate. The user sits on the medical toilet which conducts measurements that include a resting heart rate measurement (the first measurement) and an electrocardiogram (EKG) reading (the second measurement). Because the user is an endurance athlete, the controller instructs the toilet to extend the time of collection of the resting heart rate measurement in order to collect a statistically significant number of cardiac contraction events. The two measurements are transmitted to the controller which uses the EKG reading to determine the validity of the resting heart rate measurement. If the resting heart rate measurement is assigned an indicator value that suggests a valid measurement, the controller may store this information. The next time the same user requires a resting heart rate measurement, the controller may signal the medical toilet to conduct the measurement under the same parameters. Alternatively, if the indicator value suggests that the resting heart rate measurement as conducted did not result in a valid measurement, the controller may signal the medical toilet to adjust the parameters under which the measurement is taken and repeat the measurement using the modified parameters. In this example, the controller signaled the medical toilet to both lengthen the collection time and measure the resting heart rate through a different part of the user's body. If these parameters are successful, the controller will record them and the next resting heart rate measurement for this user may be conducted according to the second set of parameters. Consequently, the system is able to “learn” the best method to measure a particular physiological event for each user. -
FIG. 5 illustrates a scenario in which the measurements produced data that are significantly inconsistent with the physical, demographical, and medical status information stored in the user information file for that user. The physical, demographical, and medical status information that is stored in the user information file indicates that the user is an obese female whose height is 5 foot 2 inches. The user sits on the medical toilet and the controller signals the medical toilet to measure bioimpedance, body weight, and blood pressure. The data collected by the measurements are transmitted to the controller. The controller analyzes the measurements and determines that the values are not consistent with those expected for an obese female whose height is 5 foot 2 inches. For example, the measurements may have indicated that the user's body weight is 120 pounds, her blood pressure is within the lower end of the normal range for a healthy adult, and a body fat calculation may have provided a low value. The controller may then instruct the medical toilet to repeat the measurements using parameters that it would have selected for a non-obese user. The controller may provide a report which includes both sets of measurements, noting the inconsistency with the physical, demographical, and medical status information provided for that user in her user information file. The controller may also suggest that the physical, demographical, and medical status information in that user's user information file should be updated (perhaps the user lost significant body fat) or that the wrong user identification information was entered prior to performing the measurements. Thus, not only may an improper interpretation of the data have been avoided, but an error in medical recordkeeping may have been avoided. For example, if the controller was connected to a computerized medical recordkeeping system, an incorrect user identification could have caused the measurements to be stored in the wrong patient file. -
FIG. 6 is a diagram illustrating a scenario in which the controller uses physical, demographical, and medical status in the user information file to select appropriate measurements, to select appropriate calculations to be performed using the data collected by the measurements, as well as appropriate adjustable parameters to use when conducting the measurements. In the example ofFIG. 6 , the user is a female endurance athlete who is diabetic and on medication for her diabetes. One of the chosen measurements is resting heart rate. As discussed in reference to the example ofFIG. 4 , an endurance athlete may have a low resting heart rate. For this reason, the controller adjusts the parameters of the measurement to increase the time the heart rate is measured and to measure the heart rate in the user's neck where the carotid artery is located. The carotid artery is expected to give a stronger signal than other parts of the body. A female endurance athlete often has reduced levels of steroid hormones which may interfere with normal menstrual cycling and fertility. For this reason, the controller signals the toilet to measure urine steroid hormones and to adjust the parameters to accurately measure within a lower than normal range of detection. This user is likely to have a low percent body fat so the measurements that will be used to calculate body fat will also be adjusted to accurately measure within a low range of detection. An athlete is likely to have elevated serum high density lipoproteins (HDL) so the parameters are adjusted to accurately measure HDLs in the upper range. Body mass index (BMI) is not meaningful for very fit individuals so this calculation is not performed or reported. Finally, because the user is a diabetic and medicated for her diabetes, the controller signals the medical toilet to measure serum glucose levels and quantify the amount of her medication or metabolites thereof in her urine. The latter may be used to confirm drug compliance or, along with serum glucose levels, to assess the appropriateness of her prescribed drug and its dosage. -
FIG. 7 is a flow chart illustrating a method of using an embodiment of the invention to confirm drug compliance and appropriateness of dosage. The physical, demographical, and medical status stored in the user's user information file in the controller indicates that the user is on a prescription medication that has a common side effect of lowered heart rate. Therefore, the controller selects a heart rate measurement for this user to determine if the drug has lowered the user's heart rate to an unsafe level. The chosen parameters are an extended measurement time and collection from the user's neck near the carotid artery in an attempt to get a valid measurement from a user that may have a slow heart rate. However, the heart rate measurement indicates that the user has an elevated heart rate. This is an unexpected result for a user who is currently taking this drug. Consequently, the controller signals the medical toilet to measure the presence of the user's drug or metabolites thereof in the user's urine. If the urine analysis indicates low or absent drug in the user's body, the controller may provide a report suggesting that the user has not taken the medication, the dosage is too low, or a different medication may be appropriate. - While specific embodiments have been illustrated and described above, it is to be understood that the disclosure provided is not limited to the precise configuration, steps, and components disclosed. Various modifications, changes, and variations apparent to those of skill in the art may be made in the arrangement, operation, and details of the methods and systems disclosed, with the aid of the present disclosure.
- Without further elaboration, it is believed that one skilled in the art can use the preceding description to utilize the present disclosure to its fullest extent. The examples and embodiments disclosed herein are to be construed as merely illustrative and exemplary and not a limitation of the scope of the present disclosure in any way. It will be apparent to those having skill in the art that changes may be made to the details of the above-described embodiments without departing from the underlying principles of the disclosure herein.
Claims (20)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/360,101 US10441252B2 (en) | 2016-11-23 | 2016-11-23 | Medical toilet with user customized health metric validation system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/360,101 US10441252B2 (en) | 2016-11-23 | 2016-11-23 | Medical toilet with user customized health metric validation system |
Publications (2)
Publication Number | Publication Date |
---|---|
US20180140284A1 true US20180140284A1 (en) | 2018-05-24 |
US10441252B2 US10441252B2 (en) | 2019-10-15 |
Family
ID=62144532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/360,101 Active 2037-09-14 US10441252B2 (en) | 2016-11-23 | 2016-11-23 | Medical toilet with user customized health metric validation system |
Country Status (1)
Country | Link |
---|---|
US (1) | US10441252B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020257357A1 (en) * | 2019-06-17 | 2020-12-24 | Medic, Inc. | Toilet with infrastructure for analytical devices |
US20220022810A1 (en) * | 2020-07-23 | 2022-01-27 | Medic, Inc. | Treatment Compliance Tracking by Measuring Symptoms with an Analytical Toilet |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6351666B1 (en) * | 1998-02-27 | 2002-02-26 | Biofield Corp. | Method and apparatus for sensing and processing biopotentials |
US20040225449A1 (en) * | 1999-06-28 | 2004-11-11 | Bevilacqua Michael P. | Systems and methods for characterizing a biological condition or agent using selected gene expression profiles |
US20050261605A1 (en) * | 2002-10-18 | 2005-11-24 | S.A.E. Afikim Computerized Dairy Management System | System for monitoring the health of an individual and method for use thereof |
US20120262298A1 (en) * | 2011-04-15 | 2012-10-18 | Dexcom, Inc. | Advanced analyte sensor calibration and error detection |
US20140012116A1 (en) * | 2011-03-23 | 2014-01-09 | Panasonic Corporation | Living organism information measurement device |
US20150164343A1 (en) * | 2013-12-13 | 2015-06-18 | Industrial Technology Research Institute | Management systems and methods for managing physiology data measurement |
-
2016
- 2016-11-23 US US15/360,101 patent/US10441252B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6351666B1 (en) * | 1998-02-27 | 2002-02-26 | Biofield Corp. | Method and apparatus for sensing and processing biopotentials |
US20040225449A1 (en) * | 1999-06-28 | 2004-11-11 | Bevilacqua Michael P. | Systems and methods for characterizing a biological condition or agent using selected gene expression profiles |
US20050261605A1 (en) * | 2002-10-18 | 2005-11-24 | S.A.E. Afikim Computerized Dairy Management System | System for monitoring the health of an individual and method for use thereof |
US20140012116A1 (en) * | 2011-03-23 | 2014-01-09 | Panasonic Corporation | Living organism information measurement device |
US20120262298A1 (en) * | 2011-04-15 | 2012-10-18 | Dexcom, Inc. | Advanced analyte sensor calibration and error detection |
US20150164343A1 (en) * | 2013-12-13 | 2015-06-18 | Industrial Technology Research Institute | Management systems and methods for managing physiology data measurement |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020257357A1 (en) * | 2019-06-17 | 2020-12-24 | Medic, Inc. | Toilet with infrastructure for analytical devices |
US20220022810A1 (en) * | 2020-07-23 | 2022-01-27 | Medic, Inc. | Treatment Compliance Tracking by Measuring Symptoms with an Analytical Toilet |
Also Published As
Publication number | Publication date |
---|---|
US10441252B2 (en) | 2019-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Batsis et al. | Diagnostic accuracy of body mass index to identify obesity in older adults: NHANES 1999–2004 | |
Mage et al. | Creatinine corrections for estimating children's and adult's pesticide intake doses in equilibrium with urinary pesticide and creatinine concentrations | |
Bartko | The intraclass correlation coefficient as a measure of reliability | |
Rahman et al. | IoT-based personal health care monitoring device for diabetic patients | |
Silveira et al. | Methods for classifying obesity in spinal cord injury: a review | |
Madlon-Kay | Recognition of the presence and severity of newborn jaundice by parents, nurses, physicians, and icterometer | |
Al-Gindan et al. | Predicting muscle mass from anthropometry using magnetic resonance imaging as reference: a systematic review | |
JP3565051B2 (en) | Health management device | |
KR20090024808A (en) | Assessing dementia and dementia-type disorders | |
Nickerson et al. | Agreement between 2 segmental bioimpedance devices, BOD POD, and DXA in obese adults | |
US20210005322A1 (en) | Biological fluid analysis and personalized hydration assessment systems | |
EP3483606A1 (en) | Health monitoring system, health monitoring method, and health monitoring program | |
US20180085008A1 (en) | Health Metric Validation System | |
US10441252B2 (en) | Medical toilet with user customized health metric validation system | |
Stone et al. | Comparison of bioelectrical impedance analysis and dual-energy x-ray absorptiometry for estimating bone mineral content | |
JP2008547078A (en) | Living body age measuring apparatus and service method thereof | |
Mukherjee et al. | MenstruLoss: sensor for menstrual blood loss monitoring | |
Mobbs | From the Subjective to the Objective era of outcomes analysis: how the tools we use to measure outcomes must change to be reflective of the pathologies we treat in spinal surgery | |
DiLiberto et al. | Use of time-to-boundary to assess postural instability and predict functional mobility in people with diabetes mellitus and peripheral neuropathy | |
Patil et al. | Single prediction equation for bioelectrical impedance analysis in adults aged 22–59 years | |
Madlon-Kay | Home health nurse clinical assessment of neonatal jaundice: comparison of 3 methods | |
US20180052955A1 (en) | Health Condition Determination System | |
CN112331283A (en) | Health monitoring method, device and computer readable medium | |
Nolte et al. | Vibration threshold in non-diabetic subjects | |
Sardinha et al. | Development and validation of bioelectrical impedance prediction equations estimating regional lean soft tissue mass in middle-aged adults |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: HALL LABS LLC, UTAH Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PEARMAN, TERRECE;REEL/FRAME:046834/0374 Effective date: 20180811 Owner name: HALL LABS LLC, UTAH Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KANG, MIN;REEL/FRAME:046832/0521 Effective date: 20180811 Owner name: HALL LABS LLC, UTAH Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HALL, DAVID R;REEL/FRAME:046832/0478 Effective date: 20180811 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
AS | Assignment |
Owner name: HALL LABS LLC, UTAH Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KANG, MIN;REEL/FRAME:049200/0735 Effective date: 20180811 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT RECEIVED |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
AS | Assignment |
Owner name: HALL LABS LLC, UTAH Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SWENSON, BEN;REEL/FRAME:051760/0852 Effective date: 20200117 Owner name: HALL LABS LLC, UTAH Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ALLEN, DAN;REEL/FRAME:051856/0824 Effective date: 20200111 |
|
AS | Assignment |
Owner name: MEDIC, INC., UTAH Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HALL LABS LLC;REEL/FRAME:052671/0795 Effective date: 20200407 |
|
FEPP | Fee payment procedure |
Free format text: SURCHARGE FOR LATE PAYMENT, SMALL ENTITY (ORIGINAL EVENT CODE: M2554); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Year of fee payment: 4 |
|
AS | Assignment |
Owner name: GUARDIAN HEALTH, INC., UTAH Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MEDIC, INC.;REEL/FRAME:066337/0771 Effective date: 20240116 |